Managing Orthodontic Treatment During Chemotherapy

Why chemotherapy affects orthodontic treatment

Chemotherapy drugs target rapidly dividing cells, which is why they are effective against cancer — but they also affect rapidly dividing healthy cells, including those of the oral mucosa, bone marrow, and periodontium. This creates a range of oral side effects that directly interfere with orthodontic appliances and tooth movement. The three most clinically significant problems for orthodontic patients are oral mucositis, neutropenia, and thrombocytopenia. Radiation therapy to the head and neck adds further considerations including dry mouth and osteoradionecrosis risk, which are addressed separately below.

Oral mucositis and fixed appliances

Oral mucositis — painful inflammation and ulceration of the oral mucosa — affects up to 40% of patients receiving standard chemotherapy and up to 80% of those receiving high-dose regimens for haematological malignancies. Mucositis typically begins five to ten days after a chemotherapy cycle and resolves two to three weeks later in most cases. Fixed orthodontic brackets have sharp edges that press against inflamed mucosa, converting what would be a manageable ulcer into a deeply painful and sometimes infected lesion. Most patients with active mucositis find fixed braces intolerable during affected periods. If a patient is mid-orthodontic treatment when chemotherapy begins, the orthodontist will typically remove the archwire and either leave brackets in place or debond entirely, depending on how prolonged the treatment is expected to be. Orthodontic wax can temporarily reduce bracket irritation but is not sufficient during moderate to severe mucositis.

Neutropenia and infection risk at orthodontic appointments

Neutropenia — a reduction in circulating neutrophils — is a predictable consequence of most myelosuppressive chemotherapy regimens. At its nadir, typically seven to fourteen days after chemotherapy administration, the patient's ability to fight bacterial, fungal, and viral infections is severely compromised. Orthodontic procedures that breach the oral mucosa or introduce bacteria — bracket bonding using etch and bond, wire changes that abrade the mucosa, and extraction of teeth — carry increased infection risk during neutropenic periods. The standard approach is to schedule all elective orthodontic appointments during the window when neutrophil counts have recovered, typically three to four weeks after the previous chemotherapy cycle and before the next. Active orthodontic treatment should not proceed if the patient's neutrophil count is below 1.0 × 10⁹/L; ideally counts should be above 1.5 × 10⁹/L before any elective oral procedure. Your oncology team will advise on blood count timing.

Thrombocytopenia and bleeding risk

Thrombocytopenia — low platelet count — accompanies most chemotherapy-induced bone marrow suppression. Low platelets increase bleeding risk from any minor oral trauma, including the small mucosal lacerations caused by archwire changes and new bracket bonding. Orthodontic procedures should be avoided if platelet count is below 50 × 10⁹/L; counts below 20 × 10⁹/L represent a serious spontaneous bleeding risk from any oral manipulation. As with neutropenia, timing orthodontic appointments to the recovery phase of each chemotherapy cycle, confirmed with blood count checking, minimises this risk.

Why treatment is typically paused during active chemotherapy

Given the cumulative effects of mucositis, neutropenia, thrombocytopenia, and general fatigue and malaise, active orthodontic treatment is almost always paused during chemotherapy. This is a planned, managed pause rather than an emergency situation. The orthodontist will place passive holding wires or debond brackets depending on the likely treatment duration, provide a removable retainer if appropriate, and schedule a review appointment once the oncology team confirms the acute treatment phase is complete. During the pause, some tooth relapse may occur, particularly if teeth were recently moved, but the priority is patient safety and comfort during a medically demanding period.

Temporary retainers during a treatment pause

A removable Essix-style thermoplastic retainer can be made from current models at the time of pausing treatment to hold tooth positions. This allows brackets to be removed, reducing mucositis risk and improving oral hygiene, while maintaining the progress made. Clear aligner trays already in progress can sometimes serve a retaining function in their current form. Bonded fixed retainers are generally avoided during active chemotherapy because the wire edges and composite cannot be easily modified if the patient develops mucositis or requires urgent dental intervention.

Resuming treatment after remission and bone marrow recovery

Once chemotherapy is complete and the haematology or oncology team confirms adequate bone marrow recovery — typically confirmed by full blood count at three months post-treatment — orthodontic treatment can usually resume. Full recovery of the oral mucosa and salivary function occurs within weeks to months of completing chemotherapy in most cases. Before resuming active treatment, the orthodontist will take updated records and assess whether tooth positions have changed significantly during the pause, whether root lengths are satisfactory on updated X-rays, and whether any post-chemotherapy dental problems such as increased caries need addressing first. Root resorption risk from orthodontic forces is not significantly elevated by chemotherapy in itself, though any reduction in bone density during treatment is factored into force levels applied.

How chemotherapy affects tooth development in children

Children who receive chemotherapy during active dental development — particularly for haematological cancers treated with intensive regimens in the primary school years — may experience disrupted tooth development. Effects include shortened or blunted roots on permanent teeth, enamel hypomineralisation, microdontia, and in severe cases failure of tooth development. These changes affect orthodontic planning: shortened roots are more susceptible to further resorption during orthodontic treatment and require reduced forces and careful monitoring. The oncology team's dental records from treatment will guide the orthodontist's risk assessment when treatment eventually begins.

Dry mouth from head and neck radiation and caries risk with fixed appliances

Radiation to the head and neck — used for nasopharyngeal, oral, and salivary gland cancers — can cause permanent xerostomia (dry mouth) by damaging the salivary glands. Saliva is critical for remineralising enamel and washing away cariogenic bacteria. Patients with radiation-induced dry mouth have dramatically elevated caries risk, which is compounded by fixed orthodontic appliances that create additional plaque retention sites and make oral hygiene more demanding. Fixed braces in a xerostomic patient are associated with high rates of white spot lesion formation and frank cavitation around brackets. Clear aligners do not carry this risk in the same way, since they are removable and teeth can be brushed and fluoride gel applied freely. For post-radiation patients starting orthodontics, clear aligners with intensive fluoride supplementation are preferable to fixed appliances wherever treatment complexity allows.

UK Macmillan and NHS dental support resources

Macmillan Cancer Support provides information specifically on dental and oral health during cancer treatment, including guidance on managing mouth sores, dry mouth, and oral hygiene. NHS dental services are available to patients who are exempt from charges due to a current cancer diagnosis under the Cancer Exemption Certificate scheme, which covers the period of treatment and for the year following. Patients should inform their dentist and orthodontist of their cancer diagnosis and current treatment so that appointments can be timed appropriately and dental records updated. Many NHS cancer centres have a specialist oncology liaison dentist or dental hygienist who can provide coordinated oral health support during the treatment period.

Useful related pages

This guide is for general information only. It is not a diagnosis, treatment plan, or substitute for advice from a registered dentist or orthodontist.